AMERICAN BATTERY TECHNOLOGY (ABAT)

US02451V3096 - Common Stock

1.11  0 (0%)

After market: 1.11 0 (0%)

Fundamental Rating

1

Overall ABAT gets a fundamental rating of 1 out of 10. We evaluated ABAT against 156 industry peers in the Metals & Mining industry. ABAT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ABAT is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year ABAT has reported negative net income.
In the past year ABAT has reported a negative cash flow from operations.
In the past 5 years ABAT always reported negative net income.
In the past 5 years ABAT always reported negative operating cash flow.

1.2 Ratios

ABAT's Return On Assets of -87.06% is on the low side compared to the rest of the industry. ABAT is outperformed by 96.15% of its industry peers.
The Return On Equity of ABAT (-108.32%) is worse than 88.46% of its industry peers.
Industry RankSector Rank
ROA -87.06%
ROE -108.32%
ROIC N/A
ROA(3y)-53.21%
ROA(5y)-2877.88%
ROE(3y)-62.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ABAT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

ABAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ABAT has more shares outstanding
Compared to 5 years ago, ABAT has more shares outstanding
Compared to 1 year ago, ABAT has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -2.86, we must say that ABAT is in the distress zone and has some risk of bankruptcy.
ABAT has a Altman-Z score of -2.86. This is amonst the worse of the industry: ABAT underperforms 91.67% of its industry peers.
ABAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.86
ROIC/WACCN/A
WACC10.78%

2.3 Liquidity

A Current Ratio of 1.55 indicates that ABAT should not have too much problems paying its short term obligations.
The Current ratio of ABAT (1.55) is worse than 73.08% of its industry peers.
ABAT has a Quick Ratio of 1.53. This is a normal value and indicates that ABAT is financially healthy and should not expect problems in meeting its short term obligations.
ABAT has a Quick ratio of 1.53. This is comparable to the rest of the industry: ABAT outperforms 50.64% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.53

0

3. Growth

3.1 Past

ABAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -94.10%.
EPS 1Y (TTM)-94.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y103.73%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1845.23%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

ABAT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 36.27, which means the current valuation is very expensive for ABAT.
The rest of the industry has a similar Price/Forward Earnings ratio as ABAT.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, ABAT is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 36.27

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ABAT!.
Industry RankSector Rank
Dividend Yield N/A

AMERICAN BATTERY TECHNOLOGY

NASDAQ:ABAT (12/20/2024, 8:00:00 PM)

After market: 1.11 0 (0%)

1.11

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)02-12 2025-02-12/amc
Inst Owners7.42%
Inst Owner Change1.45%
Ins Owners5.66%
Ins Owner Change27%
Market Cap82.72M
Analysts82.86
Price Target9.18 (727.03%)
Short Float %9.71%
Short Ratio14.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-146.58%
Min EPS beat(2)-161.44%
Max EPS beat(2)-131.73%
EPS beat(4)0
Avg EPS beat(4)-146.33%
Min EPS beat(4)-243.14%
Max EPS beat(4)-49.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-96.06%
Min Revenue beat(2)-98.52%
Max Revenue beat(2)-93.6%
Revenue beat(4)0
Avg Revenue beat(4)-98.03%
Min Revenue beat(4)-100%
Max Revenue beat(4)-93.6%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)20%
EPS NQ rev (1m)50%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)121.43%
Revenue NQ rev (1m)0.27%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)8.75%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 36.27
P/S 151.65
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)-0.82
EYN/A
EPS(NY)0.03
Fwd EY2.76%
FCF(TTM)-0.33
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.01
BVpS0.8
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -87.06%
ROE -108.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.21%
ROA(5y)-2877.88%
ROE(3y)-62.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 240.19%
Cap/Sales 1278.28%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.53
Altman-Z -2.86
F-Score5
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)15252%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y103.73%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1845.23%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-86.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.37%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-50.85%
OCF growth 3YN/A
OCF growth 5YN/A